Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone

R. N. ROSENTHAL ; W. LING ; P. CASADONTE ; F. VOCCI ; G. L. BAILEY ; K. KAMPMAN ; A. A. PATKAR ; S. CHAVOUSTIE ; C. BLASEY ; S. C. SIGMON ; K. L. BEEBE | 2013
Dans Addiction (Vol.108, n°12, December 2013) Article : Périodique

Aims: To evaluate the safety and efficacy of buprenorphine implants (BI) versus placebo implants (PI) for the treatment of opioid dependence. A secondary aim compared BI to open-label sublingual buprenorphine/naloxone tablets (BNX). Design: Ran[...]

Plus d'info

Ajouter à la sélection

Lien externe

Buprenorphine implants for treatment of opioid dependence. A randomized controlled trial

W. LING ; P. CASADONTE ; G. BIGELOW ; K. M. KAMPMAN ; A. A. PATKAR ; G. L. BAILEY ; R. N. ROSENTHAL ; K. L. BEEBE | 2010
Dans Journal of the American Medical Association (Vol.304, n°14, October 13, 2010) Article : Périodique

Context: Limitations of existing pharmacological treatments for opioid dependence include low adherence, medication diversion, and emergence of withdrawal symptoms. Objective: To determine the efficacy of buprenorphine implants that provide a l[...]

Plus d'info

Ajouter à la sélection

Lien externe

Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use

M. D. STEIN ; S. R. KENNEY ; B. J. ANDERSON ; G. L. BAILEY | 2019
Dans Journal of Substance Abuse Treatment (Vol.104, September 2019) Article : Périodique

Background: Fentanyl-adulterated heroin supply chains are increasing risks for fatal overdose in the U.S. Objective: The current study examined the use of overdose risk reduction behaviors among persons seeking treatment for heroin use and whet[...]

Plus d'info

Ajouter à la sélection